Citation 5566

SUZUKI,A: SHIROTA,O: MORI,K: SEKITA,S: FUCHINO,H: TAKANO,A: KUROYANAGI,M:. (2009). LEISHMANICIDAL ACTIVE CONSTITUENTS FROM NEPALESE MEDICINAL PLANT TULSI (OCIMUM SANCTUM L.). 57(3)

Citation Details

Title	LEISHMANICIDAL ACTIVE CONSTITUENTS FROM NEPALESE MEDICINAL PLANT TULSI (OCIMUM SANCTUM L.)
Authors	SUZUKI,A: SHIROTA,O: MORI,K: SEKITA,S: FUCHINO,H: TAKANO,A: KUROYANAGI,M:
Year	2009
Volume	57
Issue	3

Summary

Year: 2009

Journal: Unknown

Organisms and Their Experiments (1)

Ocimum sanctum (LAMIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVAN,3-4'-DIOL,6-ALLYL-3',8-DIMETHOXY:	None
2	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN,3-4'-DIOL,6-ALLYL-3',8-DIMETHOXY:	INACTIVE
3	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVAN,4'-OL,6-ALLYL-3-(4-ALLYL-2-METHOXYPHENOXY0-3',8-DIMETHOXY:-HYDROXY-7-METHOXY: (-):	None
4	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN,4'-OL,6-ALLYL-3-(4-ALLYL-2-METHOXYPHENOXY0-3',8-DIMETHOXY:-HYDROXY-7-METHOXY: (-):	INACTIVE
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BENZOFURAN,2,3-DIHYDRO,5-ALLYL-3-(4-ALLYL-2-METHOXYPHENOXYMETHYL)-2-(4-HYDROXY-3-METHOXYPHENYL)-7-METHOXY:	None
6	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,2,3-DIHYDRO,5-ALLYL-3-(4-ALLYL-2-METHOXYPHENOXYMETHYL)-2-(4-HYDROXY-3-METHOXYPHENYL)-7-METHOXY:	ACTIVE
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PROPANE,3-METHOXY:1,2-BIS-(4-ALLYL-2-METHOXYPHENOXY)-3-(4-HYDROXY-3-METHOXYPHENYL):	None
9	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PROPANE,1-(4-HYDROXY-3-METHOXY-PHENYL)-1,2,3-TRIS-(4-ALLYL-2-METHOXY-PHENOXY):	None
10	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPANE,1-(4-HYDROXY-3-METHOXY-PHENYL)-1,2,3-TRIS-(4-ALLYL-2-METHOXY-PHENOXY):	WEAK ACTIVITY
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BENZENE,5-METHOXY:1-ALLYL-4-(5-ALLYL-2-HYDROXY-3-METHOXYPHENOXY)-3-(4-ALLYL-2-METHOXYPHENOXY):	None
12	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZENE,5-METHOXY:1-ALLYL-4-(5-ALLYL-2-HYDROXY-3-METHOXYPHENOXY)-3-(4-ALLYL-2-METHOXYPHENOXY):	WEAK ACTIVITY
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PROP-1-EN,3(5-ALLYL-2-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXY-3-METHOXYPHENOXY):	None
14	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-1-EN,3(5-ALLYL-2-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXY-3-METHOXYPHENOXY):	INACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	EUGENOL	None
16	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGENOL	INACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CITRUSIN C	None
19	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FERULALDEHYDE	None
21	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FERULALDEHYDE	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	EUGENOL,BIS:	None
23	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGENOL,BIS:	ACTIVE
24	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	EUGENOL,DEHYDRO: DIISO:	None
25	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGENOL,DEHYDRO: DIISO:	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	OLEANOLIC ACID	None
27	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	URSOLIC ACID	None
29	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
30	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	STIGMASTEROL	None
31	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL	INACTIVE
32	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SITOSTEROL,BETA: 3-O-BETA-D-GLUCOPYRANOSIDE:	None
33	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CARYOPHYLLENE,BETA: OXIDE	None
34	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CARYOPHYLLENE,BETA: OXIDE	INACTIVE
35	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	APIGENIN	None
36	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	LUTEOLIN	None
38	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	INACTIVE
39	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CRYSOERIOL	None
40	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FLAVONE,7-8-DIMETHOXY-4'-5-DIHYDROXY:	None
41	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-8-DIMETHOXY-4'-5-DIHYDROXY:	INACTIVE
42	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FLAVONE,3'-7-8-TRIMETHOXY,4',5-DIHYDROXY:	None
43	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-7-8-TRIMETHOXY,4',5-DIHYDROXY:	INACTIVE
44	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	VANILLIN	None

Citation 5566

Citation Details

Summary

Organisms and Their Experiments (1)

Ocimum sanctum (LAMIACEAE)

Show SPARQL Queries (1)

Query 1